Back to Search Start Over

Transcranial direct current stimulation in patients with obsessive compulsive disorder: A randomized controlled trial

Authors :
Mohamed Saoud
Jerome Brunelin
Marine Mondino
Rémy Bation
Florent Le Camus
Centre de recherche en neurosciences de Lyon - Lyon Neuroscience Research Center (CRNL)
Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Hôpital neurologique et neurochirurgical Pierre Wertheimer [CHU - HCL]
Hospices Civils de Lyon (HCL)
Université de Lyon
CCSD, Accord Elsevier
Centre de recherche en neurosciences de Lyon (CRNL)
Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
Source :
European Psychiatry, European Psychiatry, 2019, 62, pp.38-44. ⟨10.1016/j.eurpsy.2019.08.011⟩, European Psychiatry, Cambridge University press, 2019, 62, pp.38-44. ⟨10.1016/j.eurpsy.2019.08.011⟩
Publication Year :
2019
Publisher :
HAL CCSD, 2019.

Abstract

Background: Obsessive-compulsive disorder (OCD) is a severe mental disorder with poor response to the available treatments. Neuroimaging studies have identified dysfunctions within the orbito-fronto-striato-pallido-thalamic network in patients with OCD. Here, we assessed the efficacy and safety of transcranial direct current stimulation (tDCS) applied with the cathode over the orbitofrontal cortex (OFC) and the anode over the right cerebellum to decrease OCD symptoms in patients with treatment-resistant OCD. Methods: In a randomized sham-controlled double-blind study, 21 patients with OCD were assigned to receive ten 20-min sessions (two sessions per day) of either active (2 mA) or sham tDCS. The clinical symptoms were measured using the Yale-Brown Obsessive and Compulsive Scale (YBOCS). Acute effects on the symptoms were measured from baseline to immediately after the 10 tDCS sessions. Long-lasting effects were measured 1 and 3 months after the 10th tDCS session. Results: Compared with the sham tDCS, active tDCS significantly decreased OCD symptoms immediately after the 10th tDCS session (F(1,19) = 5.26, p = 0.03). However, no significant differences were observed between the active and sham groups in terms of changes in YBOCS score or the number of responders one and 3 months after tDCS. Conclusion: Despite significant acute effects, tDCS with the cathode placed over the left OFC and the anode placed over the right cerebellum was not significantly effective in inducing a long-lasting reduction of symptoms in patients with treatment-resistant OCD.

Details

Language :
English
ISSN :
09249338 and 17783585
Database :
OpenAIRE
Journal :
European Psychiatry, European Psychiatry, 2019, 62, pp.38-44. ⟨10.1016/j.eurpsy.2019.08.011⟩, European Psychiatry, Cambridge University press, 2019, 62, pp.38-44. ⟨10.1016/j.eurpsy.2019.08.011⟩
Accession number :
edsair.doi.dedup.....3d9725c94b43b7116b054ea5e066a892